p53
Read More about this categoryShow Less
The p53 tumor suppressor is a 53 kDa nuclear phosphoprotein of 393 amino acids that is encoded by the TP53 gene (20 kb with 11 exons and 10 introns) and characterized by the presence of several structural and functional domains, including a N-terminus, a central core domain, a C-terminal region, a strongly basic carboxyl-terminal regulatory domain, a nuclear localization signal sequence and three nuclear export signal sequence. The p53 is considered as a major “guardian of genome” for its activities in a wide range of cellular events, including cell-cycle regulation, induction of apoptosis, gene amplification, DNA recombination, chromosomal segregation and cellular senescence.
Products Related to p53(152)
- GC81850p53 Bipartite NLS TFAPurity: >98.00%
p53 Bipartite NLS TFA is a bipartite nuclear localization signal derived from p53.
- GP10028tumor protein p53 binding protein fragment [Homo sapiens]/[Mus musculus]Purity: >98.00%
P53 binding protein fragment
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC81439 | SZ0232 | 924851-91-2 | >99.00% | |
SZ0232 is a selective mPGES-2 inhibitor. | ||||
| GC81850 | p53 Bipartite NLS TFA | - | >98.00% | |
p53 Bipartite NLS TFA is a bipartite nuclear localization signal derived from p53. | ||||
| GC91297 | Cholesterol-Doxorubicin | - | >95.00% | |
A prodrug form of doxorubicin | ||||
| GN10203 | Ziyuglycoside I | 35286-58-9 | >99.00% | |
| GP10028 | tumor protein p53 binding protein fragment [Homo sapiens]/[Mus musculus] | - | >98.00% | |
P53 binding protein fragment | ||||
| GP10036 | p53 tumor suppressor fragment | - | >98.00% | |
Regulates cell cycle | ||||
| GC15828 | AMG232 | 1352066-68-2 | >98.00% | |
AMG232 (AMG 232) is a potent, selective and orally available inhibitor of p53-MDM2 interaction, with an IC50 of 0.6 nM. AMG232 binds to MDM2 with a Kd of 0.045 nM. | ||||
| GC12647 | NVP-CGM097 | 1313363-54-0 | >98.50% | |
potent and selective MDM2 inhibitor | ||||
